Two cases of gastric cancer with peritoneal carcinomatosis successfully responding to combination chemotherapy of S-1 and cisplatin, leading to clinical complete response

被引:0
|
作者
Suzuki, Shuhei [1 ]
Ito, Yuriko [1 ]
Fukui, Tadahisa [1 ]
Orihara, Mika [1 ]
Nakamura, Sho [1 ]
Takahashi, Masahiro [1 ]
Fujimoto, Hiroto [2 ]
Kimura, Wataru [2 ]
Yoshioka, Takashi [1 ]
机构
[1] Yamagata Univ, Yamagata Fac Med, Dept Clin Oncol, 2-2-2 Iida Nishi, Yamagata 9909585, Japan
[2] Yamagata Univ, Yamagata Fac Med, Dept Surg 1, Yamagata, Japan
来源
INTERNATIONAL CANCER CONFERENCE JOURNAL | 2013年 / 2卷 / 04期
关键词
Gastric cancer; Clinical complete response; Cisplatin; S-1; Chemotherapy;
D O I
10.1007/s13691-013-0090-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report two cases of gastric cancer with peritoneal carcinomatosis successfully responding to combination chemotherapy of S-1 and cisplatin, leading to a clinical complete response (cCR). In case 1, a 60-year-old woman achieved a cCR after 6 cycles of S-1 and cisplatin. Eight cycles of S-1 and cisplatin and 16 cycles of S-1 alone were administered. Since treatment with S-1 alone, only observation has been performed with no recurrence. In case 2, a 63-year-old man achieved cCR after 2 cycles of S-1 and cisplatin chemotherapy. After 8 cycles of chemotherapy, cCR was confirmed, and a curative operation was performed. After surgery, a small number of viable cells were found in the pathological examination. Fifty-four reports of cCR cases of advanced non-resectable or metastatic gastric cancer with chemotherapy have been published, but none mentioned the treatment options after cCR. In this report, we show two patients choosing different paths after achieving cCR by chemotherapy. In our surgical case, residues of pathologically viable cancer cells were confirmed, so surgery might be recommended after cCR, but further investigation will be needed.
引用
收藏
页码:201 / 205
页数:5
相关论文
共 50 条
  • [41] Preoperative Chemotherapy with S-1 and Cisplatin for Highly Advanced Gastric Cancer
    Nashimoto, Atsushi
    Yabusaki, Hiroshi
    Nakagawa, Satoru
    Takii, Yasugiro
    Tsuchiya, Yoshiaki
    Otsuo, Tanaka
    ANTICANCER RESEARCH, 2009, 29 (11) : 4689 - 4696
  • [42] A feasibility study of outpatient chemotherapy with S-1 + cisplatin in patients with advanced gastric cancer
    Shunsuke Okazaki
    Takako E. Nakajima
    Jun Hashimoto
    Seiichiro Yamamoto
    Daisuke Takahari
    Ken Kato
    Tetsuya Hamaguchi
    Yasuhide Yamada
    Yasuhiro Shimada
    Kenji Tamura
    Gastric Cancer, 2013, 16 : 41 - 47
  • [43] Histological complete response in a patient with advanced biliary tract cancer treated by gemcitabine/cisplatin/S-1 combination chemotherapy: A case report
    Matsubara, Tokuhiro
    Nishida, Tsutomu
    Tomimaru, Yoshito
    Yamamoto, Masashi
    Hayashi, Shiro
    Nakajima, Sachiko
    Fukui, Koji
    Dono, Keizo
    Adachi, Shiro
    Ioka, Tatsuya
    Kanai, Masashi
    Inada, Masami
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 5 (06) : 757 - 761
  • [44] Preoperative combination chemotherapy with S-1 and low dose cisplatin against highly advanced gastric carcinoma
    Saikawa, Y
    Akasaka, Y
    Kanai, T
    Otani, Y
    Kumai, K
    Kubota, T
    Kitajima, M
    ONCOLOGY REPORTS, 2003, 10 (02) : 381 - 386
  • [45] HtrA1, a potential predictor of response to cisplatin-based combination chemotherapy in gastric cancer
    Catalano, Vincenzo
    Mellone, Pasquale
    d'Avino, Alfredo
    Shridhar, Viji
    Staccioli, Maria Pia
    Graziano, Francesco
    Giordani, Paolo
    Rossi, David
    Baldelli, Anna Maria
    Alessandroni, Paolo
    Santini, Daniele
    Lorenzon, Laura
    Testa, Enrica
    D'Emidio, Silvia
    De Nictolis, Michele
    Muretto, Pietro
    Fedeli, Stefano Luzi
    Baldi, Alfonso
    HISTOPATHOLOGY, 2011, 58 (05) : 669 - 678
  • [46] Phase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosis
    Fushida, S.
    Kinoshita, J.
    Kaji, M.
    Hirono, Y.
    Goda, F.
    Yagi, Y.
    Oyama, K.
    Sudo, Y.
    Watanabe, Y.
    Fujimura, T.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (05) : 1265 - 1272
  • [47] A phase II study of combination therapy with oral S-1 and cisplatin in elderly patients with advanced gastric cancer
    Sasaki, Yusuke
    Iwasa, Satoru
    Okazaki, Shunsuke
    Goto, Masahiro
    Kojima, Yasushi
    Naganuma, Atsushi
    Nagashima, Kengo
    Nagai, Yushi
    Hirano, Hidekazu
    Honma, Yoshitaka
    Takashima, Atsuo
    Kato, Ken
    Hamaguchi, Tetsuya
    GASTRIC CANCER, 2018, 21 (03) : 439 - 445
  • [48] Development of clinical pathway in S-1 chemotherapy for gastric cancer
    Tamaki Noie
    Toshiro Konishi
    Satoshi Nara
    Kei Ito
    Yasushi Harihara
    Kaoru Furushima
    Gastric Cancer, 2003, 6 (Suppl 1) : 58 - 65
  • [49] Impact of S-1 plus Cisplatin Neoadjuvant Chemotherapy on Scirrhous Gastric Cancer
    Kunisaki, Chikara
    Makino, Hirochika
    Kimura, Jun
    Takagawa, Ryo
    Kanazawa, Amane
    Ota, Mitsuyoshi
    Kosaka, Takashi
    Ono, Hidetaka A.
    Akiyama, Hirotoshi
    Endo, Itaru
    ONCOLOGY, 2015, 88 (05) : 281 - 288
  • [50] A predictive factor for the response to S-1 plus cisplatin in gastric cancer
    Miyazaki, Ikuko
    Kawai, Takashi
    Harada, Youji
    Moriyasu, Fuminori
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (36) : 4575 - 4582